White Biotech - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The white biotech market size was valued at USD 413.8 billion in 2025 and is estimated to grow from USD 454.6 billion in 2026 to reach USD 580.82 billion by 2031, at a CAGR of 6.21% during the forecast period (2026-2031). This report is Segmented by Type (Biofuels, Biomaterials, Biochemicals, Industrial Enzymes), Application (Bioenergy, Pharmaceuticals, Food and Beverages, Animal Feed, Other Applications), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global White Biotech Market Trends and Insights

Increasing Demand for Sustainable Industrial Processes

Decarbonization commitments are reshaping procurement criteria across chemicals, materials, and energy sectors, with corporate buyers increasingly specifying bio-based content thresholds to meet Scope 3 emissions targets. The European Union's updated Bioeconomy Strategy, released in 2024, prioritizes circular value chains that convert agricultural residues and municipal organic waste into bio-based intermediates, reducing reliance on fossil feedstocks. This policy shift is mirrored in private-sector commitments: Unilever announced in 2025 that 50% of its surfactant volumes would derive from renewable carbon by 2030, creating pull-through demand for bio-based fatty alcohols and glycerin. Carbon-pricing mechanisms in jurisdictions such as the EU Emissions Trading System and California's Low Carbon Fuel Standard assign tangible cost penalties to fossil-derived inputs, tilting total-cost-of-ownership calculations in favor of fermentation-derived alternatives even when upfront production costs remain higher. Industrial buyers are also scrutinizing supply-chain transparency, favoring suppliers that can document feedstock traceability and lifecycle carbon intensity, which advantages white biotech producers with certified sustainability frameworks such as ISCC PLUS or RSB.

Supportive Regulatory Frameworks and Green Incentives

Blending mandates and tax credits are accelerating capital deployment into biofuel and biochemical capacity. The United States Inflation Reduction Act, enacted in 2022 and operationalized through 2024-2025, offers production tax credits of up to USD 1.75 per gallon for sustainable aviation fuel that achieves a 50% lifecycle emissions reduction relative to petroleum jet fuel, with an additional USD 0.01 per percentage point of further reduction. This incentive structure has catalyzed announcements of over 20 new SAF projects in North America, including expansions by Chevron's Renewable Energy Group and partnerships between airlines and renewable-diesel producers. India's National Policy on Biofuels, amended in 2024, raised the ethanol-blending target to 20% by 2025-2026 and introduced a viability-gap funding mechanism for second-generation ethanol plants, de-risking investments in lignocellulosic conversion, according to the Ministry of Petroleum and Natural Gas, India. Brazil's RenovaBio program, which issues decarbonization credits (CBIOs) tradable on the stock exchange, generated over 40 million credits in 2024, providing a revenue stream that improves project economics for sugarcane-based biorefineries. Compliance frameworks such as the EU's Renewable Energy Directive III and ReFuelEU Aviation are creating long-term offtake certainty, which lenders require to finance capital-intensive fermentation and upgrading infrastructure.

Limited Availability of Cost-Effective Feedstocks

As competing demands, ranging from pellet exports for European power generation to applications in animal feed and food, drive up prices for agricultural residues and energy crops, the biomass feedstock markets are tightening. In late 2024, European wood-pellet prices jumped to EUR 180-220 per ton (USD 195-238 per ton). This surge was fueled by coal-to-biomass conversions in Germany and the Netherlands. As a result, cellulosic ethanol producers found themselves grappling with negative crush margins unless they could secure their own feedstock sources. Meanwhile, in the United States, corn prices rose to an average of USD 4.80 per bushel in 2025, up from USD 4.20 in 2023. This increase squeezed ethanol-refining margins, leading some facilities to temporarily halt operations during off-peak demand. For dispersed agricultural residues like wheat straw, corn stover, and sugarcane bagasse, logistics costs, covering collection, densification, and transport, often surpass USD 30-40 per tonne. This high cost diminishes the advantage these residues have over concentrated fossil feedstocks, which can be delivered more economically via pipeline or rail. While second-generation feedstocks, including municipal solid waste and industrial CO₂ streams, present diversification opportunities, they come with challenges. These feedstocks necessitate preprocessing infrastructure and navigate regulatory uncertainties, especially concerning waste-classification standards. Regions lacking established biomass supply chains face heightened feedstock risks. Here, producers are compelled to invest in agronomic extensions, storage facilities, and quality-assurance protocols before they can scale their production.

Other drivers and restraints analyzed in the detailed report include:

• Advancements in Synthetic Biology and Metabolic Engineering
• Growing Adoption of Biofuels and Bioplastics
• High Capital Investment and Infrastructure Requirements

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, biofuels represented 40.12% of total revenue, emphasizing the competitive edge ethanol and renewable diesel gain from blending mandates that ensure consistent demand. While this dominance establishes biofuels as the largest contributor to the white biotech market, their operating margins remain constrained due to price sensitivity. In Europe, sustainable aviation fuel commands a premium of USD 1.50-2.00 per liter over jet A-1, enhancing the profitability of new HEFA and alcohol-to-jet facilities. To address palm oil price volatility, biodiesel producers are increasingly adopting waste-oil feedstocks. Meanwhile, biomaterials, led by PLA and PHA, are expected to grow at a strong 7.29% CAGR, the fastest rate within the white biotech sector, particularly as spot PLA prices approach those of polypropylene.

Marking a shift from niche to mainstream, NatureWorks has launched a 75,000-tonne PLA facility in Thailand, while Balrampur Chini Mills has established an 80,000-tonne unit in India. Beverage companies are targeting 30% renewable content in their bottles, driving the adoption of bio-based PET, which is derived from sugarcane ethanol. Although industrial enzymes operate on a smaller scale, their unique functionalities enable them to achieve high margins, leading to increased use in brewing, baking, and animal feed. Biochemicals such as bio-succinic acid, aimed at high-value applications in polyurethane and solvents, are supported by the development of a 50,000-tonne plant in Iowa by DSM-Firmenich and Cargill. These advancements not only expand the scope of the white biotech market but also reduce its reliance on fuel-driven economics.

Complete Report Scope:

• By Type
  • Biofuels
  • Bioaterials
  • Biochemicals
  • Industrial Enzymes
• By Application
  • Bioenergy
  • Pharmaceuticals
  • Food and Beverages
  • Animal Feed
  • Other Applications
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Poland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Vietnam
    • Indonesia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of Middle East and Africa

Geography Analysis

North America, expected to account for 31.59% of the 2025 value, remains a key player in the white biotech market. This dominance is driven by the Inflation Reduction Act, which facilitated over USD 10 billion in biorefinery investments through substantial SAF and renewable diesel credits. Ethanol production reached 15.8 billion gallons, while renewable diesel capacity grew to 5.2 billion gallons, supported by advancements in soybean oil and used cooking oil. Canada utilizes canola and forest residues for biodiesel and biomethane production, whereas Mexico, despite limited mandates, is targeting an E10 goal by 2027. With corn supplies tightening, the region's future growth will depend on cellulosic or waste-based feedstocks, shaping the next phase of North America's white biotech market. Europe is progressing steadily, supported by the Fit for 55 package, ReFuelEU Aviation's 6% SAF mandate, and a target to produce 35 billion cubic meters of biomethane by 2030, according to the European Commission. Germany, France, and the Netherlands are deploying anaerobic digesters, while Sweden and Finland are incorporating lignin extraction into forest biorefineries. However, high feedstock costs and complex sustainability certifications are compressing margins in Southern Europe, where biomass often moves north for processing. Despite these challenges, the cascading-use principles outlined in the EU Bioeconomy Strategy ensure continued investment, strengthening Europe's position in the white biotech market.

The Asia-Pacific region is projected to achieve the fastest CAGR of 9.22% in the white biotech market, driven by China's dual-carbon objectives, India's ethanol blending progress, and palm-oil refinery projects in Southeast Asia. China approved six cellulosic ethanol plants with a combined capacity of 1.5 billion liters in 2024. India, leveraging supportive policies and abundant sugar and maize feedstock, achieved a 20% blending target in 2025, ahead of schedule by two quarters. Indonesia and Malaysia exported 8 million tonnes of biodiesel in 2025, though buyers are increasingly demanding RSPO certification. Japan and South Korea are focusing on bio-based chemicals for the cosmetic and pharmaceutical industries. Meanwhile, Australia is exploring straw-based ethanol but requires stronger policy support to scale production. This rapid growth solidifies Asia-Pacific's role as a critical demand center in the global white biotech market.

In South America, Brazil leads as the world's second-largest ethanol producer, generating 32 billion liters in 2025, supported by the RenovaBio decarbonization credit market. Brazil's competitive advantage, driven by low-cost sugarcane yields, is offset by political instability and currency fluctuations, which deter foreign investment. Argentina's soybean-based biodiesel faces declining demand from the EU, while Colombia is considering palm-oil refinery projects. These factors collectively define a mid-sized, feedstock-rich segment of the white biotech market. The Middle East and Africa, though still emerging, hold strategic potential. The UAE is constructing a 160,000-tonne PLA plant to meet European and Gulf packaging demand. Saudi Arabia, under its Vision 2030 initiative, has identified bio-based chemicals as a diversification priority. Sub-Saharan Africa, despite its abundant resources, lacks the necessary conversion infrastructure, leading to value losses from unprocessed biomass. The region's future share in the white biotech market will depend on incremental policy support and technology transfers.

List of Companies Covered in this Report:

• Lonza Group Ltd
• International Flavors & Fragrances Inc.
• Corbion NV
• DSM-Firmenich
• BASF SE
• Evonik Industries AG
• Laurus Labs
• BioSynth (EUCODIS Bioscience GmbH)
• Novozymes A/S
• Archer-Daniels-Midland Company
• Cargill, Incorporated
• Danimer Scientific
• Shree Renuka Sugars Limited
• Cosan SA
• Chevron (The Renewable Energy Group)
• Henan Alfa Chemical Co., Ltd.
• Amano Enzyme Inc
• Advanced Enzyme Technologies Ltd.
• Lesaffre International
• K-Genix Group (Lumis Biotech pvt ltd)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support